Select Medical (NYSE:SEM) Rating Reiterated by Benchmark

Select Medical (NYSE:SEM)‘s stock had its “buy” rating reaffirmed by Benchmark in a research note issued on Friday, Benzinga reports. They currently have a $48.00 price target on the health services provider’s stock. Benchmark’s price target indicates a potential upside of 42.26% from the company’s current price.

Separately, Bank of America assumed coverage on shares of Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, Select Medical presently has an average rating of “Moderate Buy” and an average target price of $39.00.

Select Medical Price Performance

NYSE:SEM opened at $33.74 on Friday. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a market cap of $4.39 billion, a price-to-earnings ratio of 16.07, a price-to-earnings-growth ratio of 2.14 and a beta of 1.42. The company has a 50 day moving average price of $35.83 and a 200-day moving average price of $32.45. Select Medical has a 1-year low of $21.28 and a 1-year high of $40.50.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing the consensus estimate of $0.61 by ($0.01). The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.91% and a return on equity of 17.50%. Select Medical’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the firm earned $0.61 earnings per share. Equities research analysts forecast that Select Medical will post 2.07 EPS for the current year.

Institutional Investors Weigh In On Select Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in SEM. Norges Bank acquired a new stake in Select Medical during the 4th quarter worth $34,320,000. Vanguard Group Inc. boosted its stake in Select Medical by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock worth $391,886,000 after purchasing an additional 650,093 shares during the last quarter. Point72 Asset Management L.P. boosted its stake in Select Medical by 179.5% during the 2nd quarter. Point72 Asset Management L.P. now owns 843,528 shares of the health services provider’s stock worth $29,574,000 after purchasing an additional 541,728 shares during the last quarter. Millennium Management LLC boosted its stake in Select Medical by 183.9% during the 2nd quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock worth $23,824,000 after purchasing an additional 440,140 shares during the last quarter. Finally, Hood River Capital Management LLC acquired a new stake in Select Medical during the 2nd quarter worth $14,819,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.